95 related articles for article (PubMed ID: 11753972)
1. Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis.
Têtu B; Brisson J; Wang CS; Lapointe H; Beaudry G; Blanchette C
Cancer; 2001 Dec; 92(11):2957-64. PubMed ID: 11753972
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer.
Têtu B; Brisson J; Lapointe H; Bernard P
Hum Pathol; 1998 Sep; 29(9):979-85. PubMed ID: 9744315
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases.
Têtu B; Brisson J; Lapointe H; Wang CS; Bernard P; Blanchette C
Breast Cancer Res Treat; 1999 May; 55(2):137-47. PubMed ID: 10481941
[TBL] [Abstract][Full Text] [Related]
4. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.
Jahkola T; Toivonen T; von Smitten K; Virtanen I; Wasenius VM; Blomqvist C
Br J Cancer; 1999 Apr; 80(1-2):167-74. PubMed ID: 10389993
[TBL] [Abstract][Full Text] [Related]
6. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
7. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
[TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
9. Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.
Escot C; Zhao Y; Puech C; Rochefort H
Breast Cancer Res Treat; 1996; 38(2):217-26. PubMed ID: 8861840
[TBL] [Abstract][Full Text] [Related]
10. Comparative prognostic value of Cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma.
Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G
Anticancer Res; 1996; 16(2):1011-8. PubMed ID: 8687092
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated fibrinolysis: the prognostic relevance of plasminogen activators uPA and tPA in human breast cancer.
Schmitt M; Jänicke F; Graeff H
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):695-702. PubMed ID: 2133250
[TBL] [Abstract][Full Text] [Related]
13. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
Häckel CG; Krueger S; Grote HJ; Oshiro Y; Hodges S; Johnston DA; Johnson ME; Roessner A; Ayala AG; Czerniak B
Cancer; 2000 Sep; 89(5):995-1003. PubMed ID: 10964329
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
Nielsen BS; Rank F; Illemann M; Lund LR; Danø K
Int J Cancer; 2007 May; 120(10):2086-95. PubMed ID: 17290405
[TBL] [Abstract][Full Text] [Related]
16. Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Nakopoulou L; Panayotopoulou EG; Giannopoulou I; Alexandrou P; Katsarou S; Athanassiadou P; Keramopoulos A
Mod Pathol; 2002 Nov; 15(11):1154-61. PubMed ID: 12429794
[TBL] [Abstract][Full Text] [Related]
17. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.
Nielsen BS; Sehested M; Timshel S; Pyke C; Danø K
Lab Invest; 1996 Jan; 74(1):168-77. PubMed ID: 8569179
[TBL] [Abstract][Full Text] [Related]
18. Proteases as prognostic markers in cancer.
Duffy MJ
Clin Cancer Res; 1996 Apr; 2(4):613-8. PubMed ID: 9816210
[TBL] [Abstract][Full Text] [Related]
19. Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Hähnel E; Harvey JM; Joyce R; Robbins PD; Sterrett GF; Hähnel R
Int J Cancer; 1993 Nov; 55(5):771-4. PubMed ID: 8244574
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Wolf C; Rouyer N; Lutz Y; Adida C; Loriot M; Bellocq JP; Chambon P; Basset P
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1843-7. PubMed ID: 8446598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]